EXENCIAL WEALTH ADVISORS, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1576151 OKLAHOMA CITY, OK

Position in GILD

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$602,635

+$70,803 QoQ

Shares Held

4,324

-0.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

EXENCIAL WEALTH ADVISORS, LLC holds $76,718,350 across 13 Drug Manufacturers - General names. GILD ranks #13 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVS	Novartis AG	108,594	$16,587,733
2	LLY	ELI LILLY & Co	17,141	$15,765,777
3	JNJ	Johnson & Johnson	41,920	$10,246,924
4	ABBV	AbbVie Inc.	41,150	$8,949,713
5	AMGN	Amgen Inc	17,401	$6,122,541
6	AZN	Astrazeneca PLC	20,162	$3,976,349
7	SNY	Sanofi	81,382	$3,920,984
8	GSK	GSK plc	55,198	$3,046,377

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$602,635	4,324	-0.2%	Shares	Sole	2026-04-28
2025-12-31	$531,832	4,333	+2.9%	Shares	Sole	2026-01-30
2025-09-30	$467,310	4,210	+21.3%	Shares	Sole	2025-10-27
2025-06-30	$384,718	3,470	+12.7%	Shares	Sole	2025-07-30
2025-03-31	$345,114	3,080	+3.2%	Shares	Sole	2025-05-09
2024-12-31	$275,724	2,985	-1.9%	Shares	Sole	2025-02-06
2024-09-30	$255,125	3,043	+0.6%	Shares	Sole	2024-10-31
2024-03-31	$221,654	3,026	-42.8%	Shares	Sole	2024-05-10
2023-12-31	$428,380	5,288	+86.1%	Shares	Sole	2024-02-13
2023-09-30	$212,979	2,842	-7.1%	Shares	Sole	2023-11-08
2023-06-30	$235,834	3,060	+3.1%	Shares	Sole	2023-08-10
2023-03-31	$246,337	2,969	+9.4%	Shares	Sole	2023-05-02
2022-12-31	$232,996	2,714	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.